213 related articles for article (PubMed ID: 31266501)
21. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
[TBL] [Abstract][Full Text] [Related]
22. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
[TBL] [Abstract][Full Text] [Related]
23. Recognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivors.
Trachtenberg E; Gurion R; Mashiach T; Tadmor T; Kedmi M; Dann EJ
Leuk Lymphoma; 2019 Dec; 60(14):3449-3454. PubMed ID: 31331223
[TBL] [Abstract][Full Text] [Related]
24. Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity.
Daniëls LA; Oerlemans S; Krol AD; Creutzberg CL; van de Poll-Franse LV
Br J Cancer; 2014 Feb; 110(4):868-74. PubMed ID: 24434433
[TBL] [Abstract][Full Text] [Related]
25. Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma.
Blaes AH; Ma L; Zhang Y; Peterson BA
Leuk Lymphoma; 2011 Nov; 52(11):2105-10. PubMed ID: 21740095
[TBL] [Abstract][Full Text] [Related]
26. Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study.
Oldervoll LM; Loge JH; Kaasa S; Lydersen S; Hjermstad MJ; Thorsen L; Holte H; Jacobsen AB; Fosså SD
BMC Cancer; 2007 Nov; 7():210. PubMed ID: 17997822
[TBL] [Abstract][Full Text] [Related]
27. Bone mineral density in pediatric survivors of Hodgkin and non-Hodgkin lymphomas.
Muszynska-Roslan K; Latoch E; Konstantynowicz J; Panasiuk A; Stewart A; Krawczuk-Rybak M
Adv Med Sci; 2014 Sep; 59(2):200-5. PubMed ID: 25323758
[TBL] [Abstract][Full Text] [Related]
28. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
[TBL] [Abstract][Full Text] [Related]
29. Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma.
Wang L; Zheng Y; Luo R; Kang K; Niedermann G; Zhao A; Wu Y
J Cancer Res Clin Oncol; 2024 Jan; 150(2):41. PubMed ID: 38280006
[TBL] [Abstract][Full Text] [Related]
30. Associations between baseline demographic, clinical and lifestyle factors, and changes in fatigue, depression, and health-related quality of life in long-term cancer survivors: a cohort study.
van der Kruk SR; Gunn KM; Mesters I; Lynch BM; Vallance JK; Boyle T
Support Care Cancer; 2021 Aug; 29(8):4711-4722. PubMed ID: 33515106
[TBL] [Abstract][Full Text] [Related]
31. Sleep quality and health-related quality of life among long-term survivors of (non-) Hodgkin lymphoma in Germany.
Hammersen F; Lewin P; Gebauer J; Kreitschmann-Andermahr I; Brabant G; Katalinic A; Waldmann A
PLoS One; 2017; 12(11):e0187673. PubMed ID: 29107959
[TBL] [Abstract][Full Text] [Related]
32. Separate diagnoses of Hodgkin lymphoma and non-Hodgkin lymphoma in an individual patient might not signify a common clonal origin.
Ganzel C; Pogrebijsky G; Krichevsky S; Neuman T; Yehuda DB
Exp Hematol; 2012 Sep; 40(9):698-704.e2. PubMed ID: 22659385
[TBL] [Abstract][Full Text] [Related]
33. Health status and quality of life among non-Hodgkin lymphoma survivors.
Smith SK; Zimmerman S; Williams CS; Zebrack BJ
Cancer; 2009 Jul; 115(14):3312-23. PubMed ID: 19452546
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.
Majhail NS; Bajorunaite R; Lazarus HM; Wang Z; Klein JP; Zhang MJ; Rizzo JD
Br J Haematol; 2009 Oct; 147(1):129-39. PubMed ID: 19573079
[TBL] [Abstract][Full Text] [Related]
35. Negative illness perceptions are related to more fatigue among haematological cancer survivors: a PROFILES study.
Schoormans D; Jansen M; Mols F; Oerlemans S
Acta Oncol; 2020 Aug; 59(8):959-966. PubMed ID: 32412348
[No Abstract] [Full Text] [Related]
36. The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivors.
Stadtbaeumer N; Müller H; Goergen H; Kreissl S; Borchmann P; Mayer A
Health Psychol; 2020 Oct; 39(10):905-911. PubMed ID: 32496079
[TBL] [Abstract][Full Text] [Related]
37. Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region.
Seland M; Holte H; Bjøro T; Schreiner T; Bollerslev J; Loge JH; Fosså SD; Kiserud CE
Leuk Lymphoma; 2015; 56(12):3306-14. PubMed ID: 25827172
[TBL] [Abstract][Full Text] [Related]
38. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
[TBL] [Abstract][Full Text] [Related]
39. Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey.
Compaci G; Conte C; Oberic L; Ysebaert L; Laurent G; Despas F
BMC Cancer; 2019 Dec; 19(1):1178. PubMed ID: 31795958
[TBL] [Abstract][Full Text] [Related]
40. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
